Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 28, 2020 02:00 ET | Source: Khondrion

Khondrion Receives Rare Pediatric Disease Designation for Sonlicromanol from US FDA

Khondrion Receives Rare Pediatric Disease Designation for Sonlicromanol from US FDA Designation granted for the treatment of MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke-like...
April 15, 2020 03:00 ET | Source: Khondrion

Khondrion highlights potential role of inflammatory lipid modulator prostaglandin E2 in COVID-19 disease and proposes potential treatment pathway with sonlicromanol

Khondrion highlights potential role of inflammatory lipid modulator prostaglandin E2 in COVID-19 disease and proposes potential treatment pathway with sonlicromanol Elevated levels of PGE2 known to...
January 27, 2020 03:00 ET | Source: Khondrion

Khondrion announces first patients dosed in Phase IIb study of Sonlicromanol for mitochondrial diseases

Khondrion announces first patients dosed in Phase IIb study of Sonlicromanol for mitochondrial diseases Study will examine impact on cognitive function from one of the most advanced disease-modifying...